Ventricular function and infarct size: the Western Washington Intravenous Streptokinase in Myocardial Infarction Trial.
J L Ritchie, M Cerqueira, C Maynard...
https://pubmed.ncbi.nlm.nih.gov/3280640/Completed
Led by University of Washington · Updated on 2016-02-10
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
To determine whether the administration of intravenous streptokinase (SK) early in the course of acute, transmural myocardial infarction would limit myocardial damage.
CONDITIONS
Intravenous Streptokinase in Acute Myocardial Infarction
Site Locations not provided
Location information for this trial is currently unavailable.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Washington
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
Men and women, aged less than 75. Myocardial infarction onset within six hours.
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
J L Ritchie, M Cerqueira, C Maynard...
https://pubmed.ncbi.nlm.nih.gov/3280640/G V Martin, F H Sheehan, M Stadius...
https://pubmed.ncbi.nlm.nih.gov/3396164/J W Kennedy, G V Martin, K B Davis...
https://pubmed.ncbi.nlm.nih.gov/3276409/University of Washington
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor